Sign in
4

Changes in Ownership

Cartesian Therapeutics, Inc. Filed Acc 0001453687-22-000044

President and CEO sold 5,443 shares at $1.81 ($9,863)

  • President and CEO acquired 10,937 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Brunn Carsten · President and CEO

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2022-03-01 Exercise or conversion : show line 1 in the form +10,937 528,895 D
2022-03-02 Sale : show line 2 in the form −5,443 $1.81 $9,863 523,452 D
Open-market sales · 5,443 sh · avg $1.81 · $9,863

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2022-03-01 Exercise or conversion : show line 3 in the form Restricted Stock Units −10,937 32,813 D
Loading xslF345X03/wf-form4_164634331527341.xml…